Flynn James E 13D/13G Filings for Fusion Pharmaceuticals Inc. (FUSN)

Flynn James E 13D and 13G filings for Fusion Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-12-18
4:45 pm
Purchase
2023-12-1413GFusion Pharmaceuticals Inc.
FUSN
Flynn James E6,401,000
8.840%
6,401,000increase
(New Position)
Filing